Rebecca Deprez-Poulain
Professeure des universités
CNU : SECTION 86 - SCIENCES DU MÉDICAMENT ET DES AUTRES PRODUITS DE SANTÉ
Laboratoire / équipe
Parcours
French and foreign degrees
- Bachelor of Science in chemistry at Juniata College (PA, USA), 1995.
- Master in organic chemistry at USTL (Lille, FR) 1996 (DEA)
- Engineer Degree in chemistry at HEI (Lille, FR) 1996.
- PhD in organic chemistry at USTL with honors (Lille, FR), 1999.
- Degree in Drug Design at the University of Lille 2 (ICPAL, Lille) 2001.
- Habilitation for research supervision (HDR) at the University of Lille 2, 2004.
- PharmD at the University of Lille 2, 2009
Prizes and Honors
- Michel Delalande Prize from the Academie Nationale de Pharmacie 2020
- Member of the Institut Universitaire de France 2015 promotion
- Research Incentive Prize “Prix d'Encouragement à la Recherche” 2009 – Société de Chimie Thérapeutique (SCT)-Servier (French Medicinal Chemistry Society)
Research & Professional experiences
2010-now: Full Professor in Medicinal Chemistry - School of Pharmacy, Lille, France.
- Team leader @ Inserm U1177 Institut Pasteur de Lille, University of Lille: www.deprezlab.fr
- Metalloprotease inhibitors in metabolic, autoimmune diseases and cancer
2002-2010: Ass. Professor- School of Pharmacy, Lille, France.
- Team leader @ CNRS UMR8525 then INSERM U1177 (formerly U761) Institut Pasteur de Lille (FR) University of Lille:www.deprezlab.fr
- Metalloprotease inhibitors in infectious metabolic diseases, osteoarthritis and Alzheimer’s disease
2001-2002: PostDoc fellow (ATER)- School of Pharmacy, Lille, France.
- Researcher @ CNRS UMR8525 Lille (FR)
- Antimalarial PfAM1 inhibitors
1999-2001: PostDoc fellow, School of Pharmacy, University of Lille2 (FR).
- Researcher @ CNRS UMR8525 Lille (FR)
- Design of heterocyclic libraries for screening on C. elegans. (coll. DeVGen.NV, Ghent, BE).
1996-1999: PhD student at CEREP.SA (Campus Pasteur, Lille, France).
- Supervisors Pr Tartar/Pr Sergheraert
- Combinatorial chemistry for the discovery & optimization of leads, application to the mu opiate receptor.